SLAMF1 and melanoma: As delineated in the preceding sections, members of the SLAM family, notably SLAMF8 and SLAMF9, play a dynamic role in tumor-immune modulation, profoundly affecting the progression and therapeutic outcomes of malignancies like colorectal cancer and melanoma [2,12,60,61,62,63].